Literature DB >> 25343005

Estimation of Drug Effectiveness by Modeling Three Time-dependent Covariates: An Application to Data on Cardioprotective Medications in the Chronic Dialysis Population.

Milind A Phadnis1, Theresa I Shireman2, James B Wetmore3, Sally K Rigler4, Xinhua Zhou1, John A Spertus5, Edward F Ellerbeck6, Jonathan D Mahnken1.   

Abstract

In a population of chronic dialysis patients with an extensive burden of cardiovascular disease, estimation of the effectiveness of cardioprotective medication in literature is based on calculation of a hazard ratio comparing hazard of mortality for two groups (with or without drug exposure) measured at a single point in time or through the cumulative metric of proportion of days covered (PDC) on medication. Though both approaches can be modeled in a time-dependent manner using a Cox regression model, we propose a more complete time-dependent metric for evaluating cardioprotective medication efficacy. We consider that drug effectiveness is potentially the result of interactions between three time-dependent covariate measures, current drug usage status (ON versus OFF), proportion of cumulative exposure to drug at a given point in time, and the patient's switching behavior between taking and not taking the medication. We show that modeling of all three of these time-dependent measures illustrates more clearly how varying patterns of drug exposure affect drug effectiveness, which could remain obscured when modeled by the more standard single time-dependent covariate approaches. We propose that understanding the nature and directionality of these interactions will help the biopharmaceutical industry in better estimating drug efficacy.

Entities:  

Keywords:  Markov model; anti-hypertensive drugs; drug interactions; medication patterns; state transition model

Year:  2014        PMID: 25343005      PMCID: PMC4203430          DOI: 10.1080/19466315.2014.920275

Source DB:  PubMed          Journal:  Stat Biopharm Res        ISSN: 1946-6315            Impact factor:   1.452


  14 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  Flexible modeling of the cumulative effects of time-dependent exposures on the hazard.

Authors:  Marie-Pierre Sylvestre; Michal Abrahamowicz
Journal:  Stat Med       Date:  2009-11-30       Impact factor: 2.373

3.  Assessing the effect of intensity when exposure varies over time.

Authors:  P M Vacek
Journal:  Stat Med       Date:  1997-03-15       Impact factor: 2.373

4.  Estimation and prediction in a multi-state model for breast cancer.

Authors:  Hein Putter; Jos van der Hage; Geertruida H de Bock; Rachid Elgalta; Cornelis J H van de Velde
Journal:  Biom J       Date:  2006-06       Impact factor: 2.207

5.  Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPS.

Authors:  Antonio Alberto Lopes; Jennifer L Bragg-Gresham; Sylvia P B Ramirez; Vittorio E Andreucci; Takashi Akiba; Akira Saito; Stefan H Jacobson; Bruce M Robinson; Friedrich K Port; Nancy A Mason; Eric W Young
Journal:  Nephrol Dial Transplant       Date:  2009-05-14       Impact factor: 5.992

Review 6.  Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis.

Authors:  Rajiv Agarwal; Arjun D Sinha
Journal:  Hypertension       Date:  2009-03-09       Impact factor: 10.190

7.  Atrial fibrillation and risk of stroke in dialysis patients.

Authors:  James B Wetmore; Edward F Ellerbeck; Jonathan D Mahnken; Milind Phadnis; Sally K Rigler; Purna Mukhopadhyay; John A Spertus; Xinhua Zhou; Qingjiang Hou; Theresa I Shireman
Journal:  Ann Epidemiol       Date:  2013-01-16       Impact factor: 3.797

8.  Discontinuation of beta-blockers and the risk of myocardial infarction in the elderly.

Authors:  Martina Teichert; Peter A G M de Smet; Albert Hofman; Jacqueline C M Witteman; Bruno H Ch Stricker
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

9.  Plotting summary predictions in multistate survival models: probabilities of relapse and death in remission for bone marrow transplantation patients.

Authors:  J P Klein; N Keiding; E A Copelan
Journal:  Stat Med       Date:  1993-12-30       Impact factor: 2.373

Review 10.  Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Hiddo J Lambers Heerspink; Toshiharu Ninomiya; Sophia Zoungas; Dick de Zeeuw; Diederick E Grobbee; Meg J Jardine; Martin Gallagher; Matthew A Roberts; Alan Cass; Bruce Neal; Vlado Perkovic
Journal:  Lancet       Date:  2009-02-25       Impact factor: 79.321

View more
  3 in total

1.  Comparative Effectiveness of Renin-Angiotensin System Antagonists in Maintenance Dialysis Patients.

Authors:  Theresa I Shireman; Jonathan D Mahnken; Milind A Phadnis; Edward F Ellerbeck; James B Wetmore
Journal:  Kidney Blood Press Res       Date:  2016-11-21       Impact factor: 2.687

2.  Comparative Effectiveness and Safety of Oral P2Y12 Inhibitors in Patients on Chronic Dialysis.

Authors:  Nishank Jain; Milind A Phadnis; Suzanne L Hunt; Junqiang Dai; Theresa I Shireman; Clayton L Davis; Jawahar L Mehta; Rafia S Rasu; S Susan Hedayati
Journal:  Kidney Int Rep       Date:  2021-07-03

3.  Effectiveness comparison of cardio-selective to non-selective β-blockers and their association with mortality and morbidity in end-stage renal disease: a retrospective cohort study.

Authors:  Theresa I Shireman; Jonathan D Mahnken; Milind A Phadnis; Edward F Ellerbeck
Journal:  BMC Cardiovasc Disord       Date:  2016-03-25       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.